
Protagenic & Phytanix Merge in All-Stock Move, Sparking Retail Frenzy
Protagenic Therapeutics (NASDAQ: PTIX) just pulled off a biotech plot twist worthy of a season finale. On May 19, shares skyrocketed over 240% following news of an all-stock merger with Phytanix Bio, forming a new entity: Phytanix, Inc. It’s a full …